Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uveal Melanoma × Data Collection × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 13 Pancreatic Neoplasms 5 Breast Neoplasms 5 Ovarian Neoplasms 3 Multiple Myeloma 3 Melanoma 3 Lymphoma 3 Uterine Cervical Neoplasms 2 Thyroid Diseases 2 Prostatic Neoplasms 2 Pancreatic Cyst 2 Neoplasm Metastasis 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Wilms Tumor 1 Venous Thrombosis 1 Venous Thromboembolism 1 Uveal Melanoma 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thrombosis 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Stomach Neoplasms 1

Interventions

Ipilimumab 14 Nivolumab 12 incomplete Freund's adjuvant 8 Cyclophosphamide 7 pembrolizumab 6 Ranibizumab 6 CTLA-4 Antigen 6 sargramostim 5 Radiosurgery 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 MART-1 Antigen 4 Biopsy 4 tebentafusp 3 aflibercept 3 Temozolomide 3 Sunitinib 3 Specimen Handling 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Bevacizumab 3 130-nm albumin-bound paclitaxel 3 olaparib 2 montanide ISA 51 2 lenvatinib 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Triamcinolone Acetonide 2 Thalidomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06432660 2026-02-06

PROMPT

Duke University

Active not recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡